Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gabor E,Linthorst

第一单位： Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, g.e.linthorst@amc.uva.nl.

作者： Gabor E,Linthorst ^[1] ; Alessandro P,Burlina ; Franco,Cecchi ; Timothy M,Cox ; Janice M,Fletcher ; Ulla,Feldt-Rasmussen ; Roberto,Giugliani ; Carla E M,Hollak ; Gunnar,Houge ; Derralynn,Hughes ; Iikka,Kantola ; Robin,Lachmann ; Monica,Lopez ; Alberto,Ortiz ; Rossella,Parini ; Alberto,Rivera ; Arndt,Rolfs ; Uma,Ramaswami ; Einar,Svarstad ; Camilla,Tondel ; Anna,Tylki-Szymanska ; Bojan,Vujkovac ; Steven,Waldek ; Michael,West ; F,Weidemann ; Atul,Mehta

作者单位： Department of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, g.e.linthorst@amc.uva.nl. ^[1]

DOI 10.1007/8904_2012_160

PMID 23430520

发布时间 2022-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JIMD reports

2013年8卷

51-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage.

JIMD reports

相似文献

JIMD reports

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage.

JIMD reports

相似文献

JIMD reports

相关期刊

检索历史清除